Showing results (1-10 of 507) with videos related to
Sort By:
Pageof 51
Biologics : Targets & Therapy|August 27, 2009
Targeted therapy of advanced non-small cell lung cancer: the role of bevacizumabThomas E StinchcombeNanomedicine (London, England)|August 25, 2007
Nanoparticle albumin-bound paclitaxel: a novel Cremphor-EL-free formulation of paclitaxelThomas E StinchcombeTranslational Lung Cancer Research|March 10, 2016
AZD9291 in epidermal growth factor receptor inhibitor-resistant non-small-cell lung cancerThomas E StinchcombeJournal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 25, 2018
Exploring Radiotherapy Targeting Strategy and Dose: A Pooled Analysis of Cooperative Group Trials of Combined Modality Therapy for Stage III NSCLCSteven E Schild, Herbert H Pang, Wen Fan, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 8, 2018
Toxicity Related to Radiotherapy Dose and Targeting Strategy: A Pooled Analysis of Cooperative Group Trials of Combined Modality Therapy for Locally Advanced Non-Small Cell Lung CancerSteven E Schild, Wen Fan, Thomas E Stinchcombe, et al.Medical Oncology (Northwood, London, England)|April 22, 2014
Unmet needs in squamous cell carcinoma of the lung: potential role for immunotherapyThomas E StinchcombeF1000Prime Reports|January 13, 2015
Recent advances in the treatment of non-small cell and small cell lung cancerThomas E StinchcombeTherapeutic Advances in Medical Oncology|August 13, 2020
Current management of RET rearranged non-small cell lung cancerThomas E StinchcombeAmerican Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 27, 2014
Novel formulations and new mechanisms of delivering chemotherapyThomas E StinchcombeCurrent Treatment Options in Oncology|March 11, 2016
The Use of EGFR Tyrosine Kinase Inhibitors in EGFR Wild-Type Non-Small-Cell Lung CancerThomas E StinchcombePageof 51